Bulletin
Investor Alert

New York Markets Open in:

Alkermes PLC

NAS: ALKS

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/205084517/composite

$

17.16

Change

0.00 0.00%

Volume

Volume 2.25m

Sep 23, 2020, 8:20 a.m.

Real time quotes

/zigman2/quotes/205084517/composite

Previous close

$ 17.16

$ 17.16

Change

-0.04 -0.23%

Day low

Day high

$17.06

$17.36

Open
Open: 17.35

52 week low

52 week high

$11.98

$21.88

Open

Market cap

$2.73B

Average volume

1.29M

P/E ratio

N/A

Rev. per Employee

$475,771

EPS

-0.80

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alks

MarketWatch News on ALKS

  1. Alkermes downgraded to neutral from buy at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  2. Alkermes stock price target cut to $20 from $31 at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  3. Alkermes downgraded to neutral from overweight at J.P. Morgan

    8:51 a.m. Feb. 14, 2020

    - Tomi Kilgore

  4. Alkermes stock price target cut to $21 from $25 at J.P. Morgan

    8:52 a.m. Feb. 14, 2020

    - Tomi Kilgore

  5. FDA told Alkermes to stop publishing Vivitrol ad

    1:12 p.m. Dec. 11, 2019

    - Jaimy Lee

  6. Alkermes to acquire Rodin Therapeutics for up to $950 million

    8:30 a.m. Nov. 18, 2019

    - Ciara Linnane

  7. Biogen shares fall 3%

    4:08 p.m. Nov. 14, 2019

    - Jaimy Lee

  8. Biogen, Alkermes MS treatment Vumerity gets FDA approval

    7:33 a.m. Oct. 30, 2019

    - Tomi Kilgore

  9. Alkermes upgraded to equal weight at Morgan Stanley

    10:09 a.m. Sept. 5, 2019

    - Tomi Kilgore

  10. Alkermes stock price target cut to $34 from $40 at Stifel Nicolaus

    8:55 a.m. Feb. 15, 2019

    - Tomi Kilgore

  11. Alkermes shares fall after FDA blocks antidepressant approval

    5:56 p.m. Feb. 1, 2019

    - Wallace Witkowski

  12. Alkermes reports positive results in late-stage trial of schizophrenia treatment

    8:01 a.m. Nov. 29, 2018

    - Ciara Linnane

  13. Alkermes halted premarket for news pending

    7:57 a.m. Nov. 29, 2018

    - Ciara Linnane

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alks

Other News on ALKS

  1. Alkermes Plc (ALKS) Investor Presentation - Slideshow

    6:52 a.m. Sept. 22, 2020

    - Seeking Alpha

  2. Alkermes 4230 shows encouraging single-agent activity

    7:19 a.m. Sept. 18, 2020

    - Seeking Alpha

  3. Alkermes ALKS 4240 shows encouraging action in solid tumors

    7:19 a.m. Sept. 18, 2020

    - Seeking Alpha

  4. Seeking Alpha Catalyst Watch

    3:30 p.m. Sept. 11, 2020

    - Seeking Alpha

  5. Alkermes sues Teva to block generic version of Vivitrol

    7:29 a.m. Sept. 10, 2020

    - Seeking Alpha

  6. LGND or ALKS: Which Is the Better Value Stock Right Now?

    11:40 a.m. Sept. 9, 2020

    - Zacks.com

  7. ANIK vs. ALKS: Which Stock Should Value Investors Buy Now?

    11:40 a.m. Aug. 21, 2020

    - Zacks.com

  8. ANIK or ALKS: Which Is the Better Value Stock Right Now?

    11:40 a.m. Aug. 5, 2020

    - Zacks.com

  9. Alkermes' (ALKS) Q2 Earnings & Revenues Surpass Estimates

    11:08 a.m. July 30, 2020

    - Zacks.com

  10. Alkermes (ALKS) Receives a Hold from H.C. Wainwright

    8:35 a.m. July 30, 2020

    - SmarterAnalyst

  11. Alkermes plc 2020 Q2 - Results - Earnings Call Presentation

    9:31 a.m. July 29, 2020

    - Seeking Alpha

  12. 10-Q: ALKERMES PLC.

    9:28 a.m. July 29, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  13. Loading more headlines...
/news/pressrelease/company/us/alks

Press Releases on ALKS

  1. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.